Search results for "From Annals of Internal Medicine"
Liraglutide affects beta-blockade for preventing variceal bleeding
A case series of 18 patients with cirrhosis indicated that adding a glucagon-like peptide-1 receptor agonist to a beta-blocker was associated with an increase in heart rate.
https://diabetes.acponline.org/archives/2020/06/12/7.htm
12 Jun 2020
Annals On Call: First-line drug therapy for type 2 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode covered a study of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists as first-line therapy.
https://diabetes.acponline.org/archives/2023/03/10/6.htm
10 Mar 2023
Heart failure hospitalizations similar with DPP-4 inhibitors and other drug options
The retrospective cohort study used data on almost 80,000 new saxagliptin users and almost 300,000 new sitagliptin users, gathered through the FDA's Mini-Sentinel program from 2006 to 2013.
https://diabetes.acponline.org/archives/2016/05/13/5.htm
13 May 2016
Annals On Call: Technology to improve diabetes management
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. This episode covers “Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.”
https://diabetes.acponline.org/archives/2019/12/13/6.htm
13 Dec 2019
Diabetes associated with cognitive decline, CABG better than PCI for diabetics
Higher HbA1c at midlife was associated with greater cognitive decline over the following 20 years, and coronary artery bypass grafting is preferable to percutaneous coronary intervention in diabetics, according to studies recently published in Annals of Internal Medicine.
https://diabetes.acponline.org/archives/2014/12/12/5.htm
12 Dec 2014
In the Clinic: type 2 diabetes
An In the Clinic article in the March 3 Annals of Internal Medicine provides a clinical overview of type 2 diabetes.
https://diabetes.acponline.org/archives/2015/03/13/5.htm
13 Mar 2015
Undiagnosed diabetes may be less common in U.S. than previously estimated
The overall prevalence of diabetes (diagnosed and confirmed undiagnosed) increased from 5.5% of the U.S. population in 1988 to 1994 to 10.8% in 2011 to 2014, according to data from the National Health and Nutrition Examination Survey (NHANES).
https://diabetes.acponline.org/archives/2017/11/10/6.htm
10 Nov 2017
HbA1c targets debated, history of SGLT-2 inhibitors explained
Experts offered differing recommendations for a patient's HbA1c target in Beyond the Guidelines, while a History of Medicine article said that the risks of sodium-glucose cotransporter-2 (SGLT-2) inhibitors could have been understood sooner.
https://diabetes.acponline.org/archives/2019/10/11/6.htm
11 Oct 2019
Meta-analyses look at effects of behavioral programs for diabetes
More intensive behavioral programs were more effective at helping patients with type 2 diabetes lower their HbA1c levels but not those with type 1, according to systematic analyses recently published in Annals of Internal Medicine.
https://diabetes.acponline.org/archives/2015/10/09/5.htm
9 Oct 2015
Albuminuria can be ruled out with quantitative point-of-care tests
To screen at-risk patients for albuminuria, quantitative tests can be used effectively at the point of care, but semiquantitative tests are not sufficiently accurate, a recent meta-analysis found.
https://diabetes.acponline.org/archives/2014/05/09/5.htm
9 May 2014